MannKind Corporation, based in Valencia, California, is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and cancer. In 2016, MannKind launched its lead product Afrezza, an inhalable form of insulin.
If you currently work at this organization, click the “Do you work here?” button to request editing privileges.
This SponsorPitch page is about MannKind Corporation and contains information about this organization's sponsorship activity, sponsorship decision makers and sponsorship preferences. This page is not endorsed by or affiliated with MannKind Corporation, though it may be actively managed and updated by company representatives. If you currently work at this organization, click the Manage Sponsor button to request management privileges. . All trademarks, service marks and copyrights are property of their respective owners.
Please log in to access this feature. Don't have an account? Sign up today!